Biometrics

Decentralized Identity Market Projected to Reach $102 Billion by 2030 with Swift Growth in Biometrics and BFSI Sector - ResearchAndMarkets.com

Retrieved on: 
Friday, February 16, 2024

The global decentralized identity market size is projected to reach USD 102 billion by 2030, growing at a CAGR of 90.3% from 2023 to 2030.

Key Points: 
  • The global decentralized identity market size is projected to reach USD 102 billion by 2030, growing at a CAGR of 90.3% from 2023 to 2030.
  • The rising need for interoperability between different identity systems is accentuating the acceptance of decentralized identity.
  • Decentralized identity solutions provide a standardized framework for identity verification that can be seamlessly integrated across various platforms, enabling interoperability and enhancing user convenience.
  • The increasing demand for decentralized identity solutions across the region is anticipated to play a vital role in driving the growth of the regional market

Smart Airport Technologies Market Report 2024-2034 - Integration of Artificial Intelligence and Machine Learning is Revolutionizing Smart Airport Operations - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 15, 2024

World revenue for the Smart Airport Technologies Market will surpass US$10.7 billion in 2024, with strong revenue growth through to 2034.

Key Points: 
  • World revenue for the Smart Airport Technologies Market will surpass US$10.7 billion in 2024, with strong revenue growth through to 2034.
  • The seamless integration of AI and ML technologies represents a transformative force in the evolution of smart airports.
  • These cutting-edge technologies empower airports with predictive analytics, facilitating operational forecasting, optimizing baggage routing, and enhancing security threat assessments.
  • These capital-intensive endeavours can strain the financial resources of airports, particularly those with limited budgets, hindering their ability to swiftly adopt smart technologies.

EnLiSense CCM Advances Validation of Real-Time IBD Inflammatory Biomarker Monitoring with Two Recent Peer-Reviewed Longitudinal Studies

Retrieved on: 
Thursday, February 15, 2024

Our innovative IBD Aware device offers the first solution for continuous, non-invasive monitoring of IBD through the power of sweat-sensing technology.

Key Points: 
  • Our innovative IBD Aware device offers the first solution for continuous, non-invasive monitoring of IBD through the power of sweat-sensing technology.
  • EnLiSense's journey reaches a significant milestone with over half a million human biomarker readings, underscoring the extensive validation of our technology.
  • These readings provide crucial data points, enhancing the precision and trustworthiness of inflammatory biomarker monitoring.
  • The studies involved measuring inflammation markers CRP, TNF-α, and IL-6 in subjects' blood and sweat continuously in subjects with and without IBD.

New Vitality Study Reveals: Employers Reduced Claims Costs by 4% and Achieved ROI of 180% from Claims Savings on Health and Wellbeing Program

Retrieved on: 
Thursday, February 15, 2024

This translates to a total direct savings of $39.8 million – a 4% reduction in claims costs – across the study group of approximately 40,000 lives from five employers over five years.

Key Points: 
  • This translates to a total direct savings of $39.8 million – a 4% reduction in claims costs – across the study group of approximately 40,000 lives from five employers over five years.
  • The analysis also found substantial productivity savings from risk improvements of 4.4 days per employee per year, which translates into $174 million in indirect savings.
  • Taking into consideration all program and incentive costs this resulted in a return on investment of 180% from direct claims savings.
  • Engagement rates across Vitality clients can vary depending on the levels of investment in the program and program support.

Smart Airport Technologies Market to Surpass $10.7 Billion by End of 2024 - Fortifying Airport Safety Through Smart Technologies

Retrieved on: 
Tuesday, February 13, 2024

DUBLIN, Feb. 13, 2024 /PRNewswire/ -- The "Smart Airport Technologies Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 13, 2024 /PRNewswire/ -- The "Smart Airport Technologies Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.
  • World revenue for the Smart Airport Technologies Market will surpass US$10.7 billion in 2024, with strong revenue growth through to 2034.
  • The seamless integration of AI and ML technologies represents a transformative force in the evolution of smart airports.
  • Improved Security and Threat Detection: Fortifying Airport Safety Through Smart Technologies
    With security standing as a paramount concern for airports, the adoption of smart technologies takes centre stage in fortifying threat detection and response capabilities.

Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter

Retrieved on: 
Tuesday, February 13, 2024

Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available Over-The-Counter (OTC) direct to consumers without a prescription.

Key Points: 
  • Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available Over-The-Counter (OTC) direct to consumers without a prescription.
  • View the full release here: https://www.businesswire.com/news/home/20240213849120/en/
    Joe Kiani, Founder and CEO of Masimo, said, “Until now, consumers and even healthcare providers had no way of knowing what pulse oximeter they could trust to use at home.
  • MightySat Medical provides a direct-to-consumer option for a medical device with hospital-grade pulse oximetry technology, Masimo SET®, whose performance has been reviewed and cleared by the FDA for medical use.
  • Now, MightySat Medical with Masimo SET® provides an FDA-cleared medical device with validated accuracy without the need for a prescription.

Enigma Biomedical - USA Announces Appointment of Hartmuth Kolb, PhD as Chief Scientific Officer

Retrieved on: 
Tuesday, February 13, 2024

Enigma Biomedical USA (EB) today announced the appointment of Hartmuth Kolb, PhD as Chief Science Officer (CSO).

Key Points: 
  • Enigma Biomedical USA (EB) today announced the appointment of Hartmuth Kolb, PhD as Chief Science Officer (CSO).
  • Dr. Kolb’s passion for innovation and scientific rigor has driven his extensive career and broad recognition.
  • He will join Enigma at the beginning of March, 2024.
  • In his 10 year tenure at Johnson & Johnson Innovative Medicine, he served as the Vice President, Neuroscience Biomarkers and Global Head of Imaging.

Chrysler Halcyon Concept Pushes Innovative Boundaries, Offers Forward-looking Vision of Brand's All-electric Future

Retrieved on: 
Tuesday, February 13, 2024

"The Chrysler Halcyon Concept creates a level of serenity that fully represents the Halcyon name.

Key Points: 
  • "The Chrysler Halcyon Concept creates a level of serenity that fully represents the Halcyon name.
  • The Chrysler Halcyon Concept is the latest in a steady progression of futuristic concepts representing the brand's electrification transformation.
  • Previously, the brand revealed the Chrysler Portal Concept in 2017, the Chrysler Airflow Concept in 2022 and the Chrysler Synthesis Cockpit Demonstrator in 2023.
  • The Chrysler Halcyon Concept, designed on the STLA Large platform, offers an aerodynamic, streamlined and uncompromising vision of the Chrysler brand's future exterior character.

Decentralized Identity Market Size, Share & Trends Analysis Report 2023-2030, Featuring Profiles of 1Kosmos, Nuggets, Dragonchain, Validated ID, R3, Avast Software & Civic Technologies

Retrieved on: 
Monday, February 12, 2024

The global decentralized identity market size is projected to reach USD 102 billion by 2030, growing at a CAGR of 90.3% from 2023 to 2030.

Key Points: 
  • The global decentralized identity market size is projected to reach USD 102 billion by 2030, growing at a CAGR of 90.3% from 2023 to 2030.
  • The rising need for interoperability between different identity systems is accentuating the acceptance of decentralized identity.
  • Decentralized identity solutions provide a standardized framework for identity verification that can be seamlessly integrated across various platforms, enabling interoperability and enhancing user convenience.
  • Decentralized identity solutions empower individuals with self-sovereign identities, giving them the freedom to manage and share their identity information as they see fit.

Depixus wins SLAS2024 Ignite Award for MAGNA™ technology

Retrieved on: 
Monday, February 12, 2024

Interactomics pioneer Depixus has won the prestigious Society for Laboratory Automation and Screening (SLAS) Ignite Award at the society’s annual International Conference and Exhibition in Boston, MA, for their novel MAGNA™ technology.

Key Points: 
  • Interactomics pioneer Depixus has won the prestigious Society for Laboratory Automation and Screening (SLAS) Ignite Award at the society’s annual International Conference and Exhibition in Boston, MA, for their novel MAGNA™ technology.
  • The award coincides with the first showing of Depixus’ ground-breaking MAGNA One™ instrument at the conference.
  • View the full release here: https://www.businesswire.com/news/home/20240212670326/en/
    Depixus CEO Gordon Hamilton receives the SLAS2024 Ignite Award from judge Severine Tamas-Lhoustau, CEO of Novoptim.
  • Depixus CEO Gordon Hamilton says, “We’re thrilled to have won this year’s Ignite Award against such stiff competition and congratulate all the other finalists.